MENU
IVVD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Invivyd (IVVD) Ownership - Who owns Invivyd?
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more
Profile
Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
203.72M
P/E Ratio
N/A
Total Cash
34.91M
Projected Growth
N/A
Total Debt
2.97M
Revenue
46.21M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
0.39 USD as % of share price
Fundamentals
IVVD
Capitalization
204M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
34.9M
Total Cash/Share
0.17
Total Debt
2.97M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.39%
Revenue
46.2M
ROE
N/A
Book Value
42.8M
P/B Ratio
4.76
Cash Flow
N/A
Earnings
-0.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
1.33
Current Revenue Per Employee
117860.00
Dividends Per Share - Security
N/A
EBITDA
-110.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
94.19
Revenue To Assets
-82.65
Shares Held By Institutions
49.3M
Shares Outstanding - Current
209M
Total Liabilities
46.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
119.589
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IVVD showed earnings on August 15, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com